Hardy Alexander bought BMRN
April 30, 2025 · Form 4 insider transaction
Hardy Alexander bought 375 shares of BioMarin Pharmaceutical Inc. at $54.14 per share, a transaction worth $20.3K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 216 days after the transaction.
Direction
Acquired (buy-side)
Shares
375
Price
$54.14
Total value
$20.3K
InsiderHardy Alexander
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateApril 30, 2025
Filing dateDecember 2, 2025
Shares owned after175,958
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the shares acquired by the reporting person on April 30, 2025, pursuant to the issuer's Employee Stock Purchase Plan.